When people ask about US surrogacy success rates, they’re usually looking at the wrong number. That 70% a clinic quotes might only cover transfer success—not the full journey from egg retrieval to bringing your baby home. I’ve seen couples sign contracts based on headline stats, only to get stuck in repeated retrieval cycles because they didn’t understand the blastocyst bottleneck.
Lab Blastocyst Rates Determine How Many Embryos You’ll Have
Before any transfer happens, embryos need to reach blastocyst stage—and this is where 40-50% typically don’t make it. Top US labs achieve 60%+ blastocyst rates, while weaker facilities might only hit 35%. Here’s a real example: retrieve 12 eggs, get 10 fertilized, end up with 4 blastocysts. That’s normal. The gap between a good lab and an average one means the difference between one transfer cycle and three. If your clinic won’t share their specific blastocyst conversion rates by age bracket, that’s a red flag. SART data breaks this down by clinic, but you need to know which numbers to look for.
Surrogate Uterine Environment Matters More Than Age
A 28-year-old surrogate with thin endometrial lining will have worse outcomes than a 35-year-old with optimal uterine receptivity. Reputable agencies screen for prior successful pregnancies, hormone levels, and endometrial thickness—not just age checkboxes. This part requires individual assessment with your actual medical reports. The transfer timing protocol (natural cycle vs. medicated, fresh vs. frozen) should match your surrogate’s specific physiology, not a one-size-fits-all calendar.
Where Surrogacy Is Legal With Transparent Success Data
US, Georgia, and Ukraine are the main options, but data transparency varies wildly. In the US, CDC-mandated reporting through SART lets you filter success rates by age, diagnosis, and transfer type for each clinic. Georgia is fully legal but lacks comprehensive national statistics—you’re relying on individual clinic self-reporting. Ukraine had detailed records pre-2022, but current data accessibility is limited. If a clinic in any country won’t show you year-by-year outcomes segmented by patient category, assume they’re hiding poor results. Legal doesn’t automatically mean accountable.
The real key to avoiding repeated cycles: pick a facility with verifiable lab metrics, understand the actual timeline for each step, and insist on seeing granular success data that matches your specific situation—not generic marketing percentages.